Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Xel Pharma Announces TCM Patch for Alzheimer’s

publication date: Sep 16, 2008

Xel Pharmaceuticals, Inc. of Utah is developing the use of a transdermal patch to deliver a TCM drug from China as a potential treatment for Alzheimer’s disease. The company announced that it has produced a prototype patch that delivers 400-800 mcg of Huperzine A per day for up to seven days. A naturally occurring alkaloid, Huperzine A is derived from the club moss Huperzia serrata. It has been in use in China as a prescription drug for dementia as well as fevers. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital